The discovery of elevated IL-6 levels in the synovium of rheumatoid arthritis led clinical trial of anti-IL6R antibody tocilizumab, paving its use in other autoimmune conditions (62) (5) such as:. Here, IL6 is linked to rheumatoid arthritis.